GSK logo

GSK (GSK)

Profile

Full Name

GSK plc

Ticker Symbol

GSK

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United Kingdom

IPO

March 28, 1980

Indexes

Not included

Website

http://www.gsk.com

Employees

68629

Key Details

Price

$34.84(-4.63%)

Market cap

Last Dividend

$0.40

TTM Dividend yield

4.46%

Annual revenue

$40.10B(+6.26% YoY)

Annual EPS

$1.59(-46.72% YoY)

PE ratio

22.01

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$34.84
GSK price is $34.84

30-Day Relative Volume

1.32
GSK 30-day relative volume is 1.32

Price Performance

Price Most recent change

-4.63%
GSK price was down -4.63% on Apr 7, 2025

Price YTD change

+3.02%
GSK price is up +3.02% since January 1st

Price 1-year change

-14.71%
GSK price is down -14.71% year-on-year

Price 3-year change

-26.73%
GSK price is down -26.73% over the past 3 years

Price Range

Price All-time high

$77.04
GSK price is currently -54.78% below its historical high of $77.04

Price 3-year low

$28.47
GSK price is currently +22.37% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$70.98B
GSK market capitalization is $70.98 billion

Market cap 3-year change

-25.81%
GSK market capitalization is down -25.81% over the past 3 years

Market cap All-time high

$148.21B
GSK market capitalization is currently -52.11% below its historical high of $148.21 billion

Market cap sector rank

97.87%
GSK market capitalization is higher than 97.87% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.08%
GSK shares outstanding is down -0.08% year-on-year

Shares Outstanding 3-Year Change

+1.26%
GSK shares outstanding is up +1.26% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.17
GSK beta is 0.17

200-day SMA

$37.91
GSK price is currently -8.11% below its 200-day simple moving average

50-day SMA

$37.60
GSK price is currently -7.35% below its 50-day simple moving average

RSI

32.03
GSK 14-day relative strength index is 32.03

Volume

1.32
GSK 30-day relative volume is 1.32

ATR

$1.14
GSK average true range is $1.14

10-day Historical Volatility

44.95%
GSK 10-day historical volatility is 44.95%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.40
GSK last dividend was $0.40 per share, with an ex-dividend date of February 21, 2025

Next Dividend

-
GSK next dividend has not yet been announced

Dividend per share

Dividend per share

$1.56
GSK annual dividend per share is $1.56

Dividend per share Sector Rank

59.3%
GSK annual dividend per share is higher than 59.3% of companies in Healthcare sector

Dividend per share 1-Year Change

+11.14%
GSK annual dividend per share is up +11.14% year-on-year

Dividend per share 3-Year Change

-43.24%
GSK annual dividend per share is down -43.24% over the past 3 years

Dividend yield

Dividend yield

4.47%
GSK annual dividend yield is 4.47%

Dividend yield Sector Rank

82.35%
GSK annual dividend yield is higher than 82.35% of companies in Healthcare sector

Other

Payout ratio

94.91%
GSK annual payout ratio is 94.91%

Dividends paid

$3.12B
GSK annual dividends paid is $3.12 billion

Free cash flow

$4.57B
GSK annual free cash flow is $4.57 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$40.10B
GSK annual revenue is $40.10 billion

Revenue Analysts estimate

$32.78B
GSK annual revenue is currently +22.32% higher than the consensus analysts' forecast

Revenue 1-year change

+6.26%
GSK annual revenue is up +6.26% year-on-year

Revenue Sector rank

97.33%
GSK annual revenue is higher than 97.33% of companies in Healthcare sector

EPS

EPS

$1.59
GSK annual earnings per share is $1.59

EPS Analysts estimate

$4.27
GSK annual earnings per share is currently -62.81% lower than the consensus analysts' forecast

EPS 1-year change

-46.72%
GSK annual earnings per share is down -46.72% year-on-year

EPS Sector rank

91.22%
GSK annual earnings per share is higher than 91.22% of companies in Healthcare sector

Profit

Gross profit

$28.54B
GSK annual gross profit is $28.54 billion

Gross margin

71.16%
GSK annual gross profit margin is 71.16%

Operating profit

$5.14B
GSK annual operating income is $5.14 billion

Operating margin

12.82%
GSK annual operating profit margin is 12.82%

Net income

$3.29B
GSK annual net profit is $3.29 billion

Net margin

8.21%
GSK annual net profit margin is 8.21%

Expenses

Total expenses

$34.96B
GSK annual total expenses is $34.96 billion

Operating expenses

$23.40B
GSK annual total operating expenses is $23.40 billion

Cost of goods sold

$11.56B
GSK annual cost of goods sold is $11.56 billion

Selling, general & administrative expenses

$14.08B
GSK annual SGA is $14.08 billion

Depreciation and amortization

$3.26B
GSK annual depreciation & amortization is $3.26 billion

Interest expense

$817.94M
GSK annual interest expense is $817.94 million

Income tax

$672.25M
GSK annual income tax is $672.25 million

EBIT & EBITDA

EBIT

$5.30B
GSK annual earnings before interest & taxes is $5.30 billion

EBITDA

$9.11B
GSK annual EBITDA is $9.11 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$74.61B
GSK annual total assets is $74.61 billion

Non current assets

$53.29B
GSK annual long term assets is $53.29 billion

Current assets

$21.33B
GSK annual total current assets is $21.33 billion

Cash and cash equivalents

$4.63B
GSK annual cash & cash equivalents is $4.63 billion

Accounts receivable

$6.98B
GSK annual accounts receivable is $6.98 billion

Inventory

$7.11B
GSK annual inventory is $7.11 billion

Liabilities

Total liabilities

$58.19B
GSK annual total liabilities is $58.19 billion

Long term liabilities

$30.97B
GSK annual total long term liabilities is $30.97 billion

Current liabilities

$27.23B
GSK annual total current liabilities is $27.23 billion

Accounts payable

$4.34B
GSK annual accounts payable is $4.34 billion

Debt

Total debt

$21.31B
GSK annual total debt is $21.31 billion

Total debt 1-year change

-7.14%
GSK annual total debt is down -7.14% year-on-year

Long term debt

$18.37B
GSK annual long term debt is $18.37 billion

Short term debt

$2.95B
GSK annual short term debt is $2.95 billion

Equity & Capital

Shareholders equity

$17.15B
GSK annual stockholders equity is $17.15 billion

Book value

$17.15B
GSK annual book value is $17.15 billion

Retained earnings

$9.78B
GSK annual retained earnings is $9.78 billion

Working capital

-$5.90B
GSK annual working capital is -$5.90 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$8.38B
GSK annual cash flow from operations is $8.38 billion

Cash from operations 1-year change

-0.54%
GSK annual cash flow from operations is down -0.54% year-on-year

Cash from investing

-$1.57B
GSK annual cash flow from investing activities is -$1.57 billion

Cash from investing 1-year change

+20.86%
GSK annual cash flow from investing activities is up +20.86% year-on-year

Cash from financing

-$6.04B
GSK annual cash flow from financing activities is -$6.04 billion

Cash from financing 1-year change

+13.95%
GSK annual cash flow from financing activities is up +13.95% year-on-year

CAPEX

CAPEX

$3.81B
GSK annual capital expenditures is $3.81 billion

CAPEX 1-year change

+30.67%
GSK annual capital expenditures is up +30.67% year-on-year

Free Cash Flow

Free cash flow

$4.57B
GSK annual free cash flow is $4.57 billion

Free cash flow 1-year change

-17.07%
GSK annual free cash flow is down -17.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

71.16%
GSK annual gross profit margin is 71.16%

Operating margin

12.82%
GSK annual operating profit margin is 12.82%

Net margin

8.21%
GSK annual net profit margin is 8.21%

ROA & ROE

ROA

4.39%
GSK annual return on assets is 4.39%

ROE

20.12%
GSK annual return on equity is 20.12%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

22.01
GSK price to earnings ratio is 22.01

PE ratio Sector rank

43.63%
GSK price to earnings ratio is higher than 43.63% of companies in Healthcare sector

PB Ratio

PB ratio

4.14
GSK price to book ratio is 4.14

PB ratio Sector rank

81.35%
GSK price to book ratio is higher than 81.35% of companies in Healthcare sector

PS Ratio

PS ratio

1.77
GSK price to sales ratio is 1.77

PS ratio Sector rank

41.36%
GSK price to sales ratio is higher than 41.36% of companies in Healthcare sector

Enterprise value

Enterprise value

$87.66B
GSK enterprise value is $87.66 billion

Enterprise value Sector rank

97.94%
GSK enterprise value is higher than 97.94% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

9.65
GSK EV/EBITDA is 9.65

EV/EBITDA Sector rank

82.12%
GSK EV/EBITDA is higher than 82.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.78
GSK annual current ratio is 0.78

Quick ratio

0.52
GSK annual quick ratio is 0.52

Leverage

Debt to equity

1.24
GSK annual debt to equity ratio is 1.24

Interest coverage ratio

6.48
GSK annual interest coverage ratio is 6.48

Risk & Stability

Piotroski F-Score

6
GSK piotroski f-score is 6

Altman Z-Score

1.59
GSK altman z-score is 1.59

Analyst ratings

Recent major analysts updates

Nov 12, 24 Jefferies
Hold
Oct 31, 24 Guggenheim
Neutral
Jul 8, 24 UBS
Neutral
Jul 2, 24 Jefferies
Buy
May 30, 24 Goldman Sachs
Neutral
Mar 4, 24 Guggenheim
Buy
Jan 23, 24 Morgan Stanley
Equal-Weight
Jan 3, 24 Jefferies
Buy
Feb 11, 22 DZ Bank
Hold
Nov 5, 21 Barclays
Equal-Weight

Institutional Ownership

Similar stocks

ZTS logo
Zoetis (ZTS)
REGN logo
Regeneron Pharmaceuticals (REGN)
CVS logo
CVS Health (CVS)
HCA logo
HCA Healthcare (HCA)
MCK logo
McKesson (MCK)
BDX logo
Becton Dickinson and Company (BDX)
CI logo
Cigna (CI)
ELV logo
Elevance Health (ELV)
TAK logo
Takeda Pharmaceutical Company Limited (TAK)
  • What is the ticker symbol for GSK?
  • Does GSK pay dividends?
  • What sector is GSK in?
  • What industry is GSK in?
  • What country is GSK based in?
  • When did GSK go public?
  • Is GSK in the S&P 500?
  • Is GSK in the NASDAQ 100?
  • Is GSK in the Dow Jones?
  • When was GSK's last earnings report?
  • When does GSK report earnings?

What is the ticker symbol for GSK?

The ticker symbol for GSK is NYSE:GSK

Does GSK pay dividends?

Yes, GSK pays dividends. The last payment was $0.40, with an ex-dividend date on February 21, 2025

What sector is GSK in?

GSK is in the Healthcare sector

What industry is GSK in?

GSK is in the Drug Manufacturers - General industry

What country is GSK based in?

GSK is headquartered in United Kingdom

When did GSK go public?

GSK's initial public offering (IPO) was on March 28, 1980

Is GSK in the S&P 500?

No, GSK is not included in the S&P 500 index

Is GSK in the NASDAQ 100?

No, GSK is not included in the NASDAQ 100 index

Is GSK in the Dow Jones?

No, GSK is not included in the Dow Jones index

When was GSK's last earnings report?

GSK's most recent earnings report was on Feb 5, 2025

When does GSK report earnings?

The next expected earnings date for GSK is Apr 30, 2025
On this page